Rtw Investments Adds $47M in Intuitive Surgical, Inc. ($ISRG)
RTW Investments significantly increased its holdings in Intuitive Surgical, reflecting confidence in the company's future.
Key Points
- RTW Investments boosted its position in Intuitive Surgical by 117%, adding 118,772 shares for a total of 220,000 shares worth about $90.4 million.
- Intuitive Surgical, traded on NasdaqGS under ISRG, has a market cap of $145.6 billion and a P/E ratio of 50.01 with a 52-week range between $396.68 and $603.88.
- Analysts maintain a 'buy' consensus for Intuitive Surgical with a target mean price of $565.08, reflecting positive sentiment among investors.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
RTW Investments has significantly increased its stake in Intuitive Surgical, Inc. (NasdaqGS: ISRG), as revealed in its latest 13F filing with the Securities and Exchange Commission. The fund added 118,772 shares, growing its holdings by 117% to a total of 220,000 shares, valued at approximately $90.4 million as of the reporting period.
What Changed in RTW Investments' Intuitive Surgical Position
RTW Investments' decision to boost its stake in Intuitive Surgical by 117% indicates a strong vote of confidence in the medical technology company. Before this move, the fund held 101,228 shares and now possesses 220,000 shares. This significant increase reflects a strategic investment decision by RTW Investments.
Other Institutional Activity in Intuitive Surgical
Among other institutional investors, BlackRock, Inc. trimmed its holdings by 440,248 shares, leaving it with 30,075,905 shares valued at about $13.9 billion. Vanguard Capital Management LLC maintained its position with 23,079,490 shares worth approximately $10.6 billion. State Street Corp added 145,382 shares, ending with 15,846,973 shares valued at $7.3 billion. Geode Capital Management, LLC increased its stake by 241,160 shares to 8,466,851 shares, valued at $3.9 billion.
Intuitive Surgical, Inc. Stock Up 6.7%
Shares of Intuitive Surgical, Inc. (NasdaqGS: ISRG) traded at around $411.06 recently. The company boasts a market cap of approximately $145.6 billion and has a P/E ratio of 50.01. Its forward P/E stands at 34.88, and it has a beta of 1.453. The stock's 52-week range is between $396.68 and $603.88, with a 50-day moving average of $443.28 and a 200-day moving average of $491.91.
$ISRG stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Intuitive Surgical reported revenues of $10.6 billion, reflecting a growth rate of 23%. The company achieved an EPS of $8.22, with a net margin of 28.15% and a return on equity of 17.23%. The next earnings report is anticipated on April 21, 2026.
Insider Buying and Selling at Intuitive Surgical, Inc.
Recent insider transactions include EVP & Chief Manufacturing and Supply Chain Officer Mark Brosius selling 25 shares on June 12, 2026, and 23 shares on June 11, 2026, at prices of $414.13 and $412.16, respectively, under planned sales. EVP & Chief Legal and Compliance Officer Gary Loeb sold 400 shares at $424.14 on June 10, 2026. CEO David Rosa sold 1,358 shares on the same day without a price listed, and also bought 1,358 shares, indicating a planned transaction.
Analysts Set New Price Targets
Analysts remain optimistic about Intuitive Surgical. On May 18, 2026, B of A Securities maintained its 'buy' rating with a $520 price target. Barclays, on April 23, 2026, also maintained a 'buy' rating with a target of $651. The consensus among analysts is a 'buy' recommendation, with an average target price of $565.08 based on 29 opinions.
About Intuitive Surgical
Intuitive Surgical, Inc., headquartered in Sunnyvale, California, develops and markets products that enhance minimally invasive care. Known for its da Vinci Surgical System, the company provides advanced tools for surgical procedures and diagnostic endoluminal procedures. Led by CEO David J. Rosa, Intuitive Surgical employs over 17,000 people and serves healthcare providers worldwide.
Bottom Line
RTW Investments' substantial increase in its Intuitive Surgical stake underscores a strong belief in the company's potential. As a leader in minimally invasive surgical technology, Intuitive Surgical continues to attract attention from institutional investors. However, it's important to remember that 13F filings are backward-looking and may not represent current positions.
Get Intuitive Surgical, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ISRG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.